Conmed Stock News

PDCO vs. CNMD: Which Stock Is the Better Value Option?

ASX, CNMD, and BHC have been added to the Zacks Rank #5 (Strong Sell) List on May 19, 2022.

Looking at stock returns, ConMed's -19% return is comparatively better than DENTSPLY's -45% change over the last twelve months.

CNMD, CL, and T have been added to the Zacks Rank #5 (Strong Sell) List on May 17, 2022.

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Conmed Corp (NYSE:CNMD ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Curt Hartman - Chairman, CEO & President Todd Garner - EVP & CFO Conference Call Participants Lili

CONMED's (CNMD) first-quarter earnings reflect strong segmental performance.

Conmed (CNMD) delivered earnings and revenue surprises of 12.90% and 2.88%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will reschedule the reporting of its first quarter 2022 financial results due to a corporate conflict. The release

CONMED (CNMD) continues to gain momentum from a solid product portfolio and strong General Surgery business. However, data security threats linger.

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2022 after the market close on Wednesday, April 27, 2022. The

HSIC vs. CNMD: Which Stock Is the Better Value Option?

New York, USA, March 01, 2022 (GLOBE NEWSWIRE) -- The Global Powered Surgical Instruments Market Is Expected To Exhibit Strong Growth With a CAGR of 4.26% In The Coming Years , Assess DelveInsight As per DelveInsight analysis, the Powered Surgical Instruments market is growing positively due to the factors such as an increase in geriatric population, having a high prevalence of bone disorders and ophthalmic conditions, and along with the increasing incidence of brain cancers as well increase in the number of trauma cases, and a parallel growth in product innovation. DelveInsight''s Powered Surgical Instruments Market Insights report provides the current and forecast Powered Surgical Instruments market, upcoming device innovation, individual leading Powered Surgical Instruments device companies market shares, challenges, drivers, barriers, and market trends and key Powered Surgical Instruments companies in the market. Key Takeaways from the Global Powered Surgical Instruments Market According to DelveInsight analysis, North America is expected to dominate the overall Powered Surgical Instruments market during the forecast period.

New York, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Minimally Invasive Surgical Systems Market: Focus on Product Type, Application, End Users, 25 Countries'' Data, Patent Scenario, and Competitive Landscape - Analysis and Forecast, 2021-2031" - https://www.reportlinker.com/p06135349/?utm_source=GNW Market Segmentation • Product - Conventional Technologies (Endoscopes and Endoscopic Systems, Video and Visualization Systems, Capsule Endoscopy, Instruments and Accessories, Others), Surgical Robotics (Robotic Systems, Instruments and Accessories, Services) • Application - General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiovascular Surgery, Neurosurgery, Others • End User - Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics • Region - North America, Europe, Asia-Pacific, Latin America, Middle East and Africa Regional Segmentation • North America - U.S., Canada • Europe - Germany, France, Spain, U.